Bot Chart, page-244

First 244 Last

Share
Profile

Follow
bernsta

3,685 Posts.

108

07/03/19

21:44

Post #: 37691489
Share

Originally posted by aburbe: ↑

Don't rule them out yet, particularly once the results for BTX1308 are out, whose trial - as you know - is in collaboration with Bioskin ( a subsidary of BAUSCH). Just because they bought Synergy does't means they're done with acquisitions for the rest of the year, they've allocated $1billion for it and their bid for Synergy was $200m - that leaves them with $800m to either pay some of their debt or chase further deals.
This is Bausch Health's Vice President and Chief Financial Officer at the last earning conference:

https://www.fool.com/earnings/call-transcripts/2019/02/20/bausch-health-companies-inc-bhc-q4-2018-earnings-c.aspx

"With respect to the question around how do we expect to deploy our cash flow, Joe finished up with a slide that said we have $1 billion to use for debt, and/or bolt-on acquisitions. Our priority, is to reduce that debt. Now, that said, it's not a priority where you say when you have a great opportunity that we think is value generative, and helpful to all stakeholders, we're going to pursue that. I think the best example of that is the ongoing situation with Synergy, where, as Joe reported in his remarks, we put in a Stalking Horse bid, it's $200 million.It's $200 million. If we were successful at that level, I'm not suggesting that's how that'll sort out, but if we are successful at that level, that $1 billion, $200 million of it would definitionally be allocated to business development. And there are other smaller items that throughout the year, we would expect to pursue, to continue to add to our R&D portfolios"If the results due next Q repeat the acne and eczema's performances there's a (good) chance that Bausch may come up with an offer to establish their position for phase 2 and/or add it outright to their R&D portfolio.

Expand

And there in lies the beauty of this opportunity.

With 4 game changing products, a market cap of 1 billion pending results is reasonable and completely fair.

BTX1503 alone is on par with roaccutane for goodness sake!

Nothing in the acne space for 20 years!

We are ridiculously cheap. This won’t be sold for under a billion dollars. Not on your life.

BOT Price at posting: 12.5¢ Sentiment: Buy Disclosure: Held
18 Upvote

0 Great analysis

Reply

Top Stories

Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL

GRL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

DUI

Panic, paranoia, and gangland politics: HotCopper users react to Dubber's missing $26M

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

LPE

Sales growth pushes Lovisa's fortunes (and shares) upwards

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

SIG

Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

PYC

Scientific conference spotlights PYC's work on blindness disease treatment

HotCopper Highlights: Your most watched stocks for Week 47, 2024

There are more pages in this discussion • 196 more messages in this thread...

First 244 Last

Add BOT (ASX) to my watchlist

(20min delay)
Last 32.0¢		Change 0.005(1.59%)		Mkt cap ! $707.4M

Open	High	Low	Value	Volume
31.5¢	32.5¢	31.0¢	$1.169M	3.655M

Buyers (Bids)

No.	Vol.	Price($)
9	274982	31.5¢

Sellers (Offers)

Price($)	Vol.	No.
32.0¢	48600	2

View Market Depth

No.	Vol.	Price($)
11	423267	0.105
23	1189777	0.100
1	10111	0.099
1	50000	0.098
1	50000	0.097

Price($)	Vol.	No.
0.110	555657	10
0.115	560304	6
0.120	829451	14
0.125	1083838	12
0.130	498290	12

Last trade - 16.10pm 22/11/2024 (20 minute delay)

BOT (ASX) Chart

Bot Chart, page-244

Top Stories

Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Panic, paranoia, and gangland politics: HotCopper users react to Dubber's missing $26M

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Sales growth pushes Lovisa's fortunes (and shares) upwards

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

Scientific conference spotlights PYC's work on blindness disease treatment

HotCopper Highlights: Your most watched stocks for Week 47, 2024

Buyers (Bids)

Sellers (Offers)